Hypertension and inflammation promote cardiovascular disease (CVD). Even high normal systolic blood pressure (SBP) is associated with increased CVD risk. We assessed the relationship of elevated SBP within the normotensive range and white blood cell (WBC) count. This is a cross-sectional study of 3484 white asymptomatic individuals (mean age: 4378 years, 79% males) without hypertension with SBPo140 mm Hg. White blood cell count X75th percentile (8.35 Â 10 9 cells/l) was considered cutoff for elevated WBC. Subjects were classified into three levels of SBP (first: o120 mm Hg, n ¼ 1176, 34%; second: 120-129 mm Hg, n ¼ 1654, 47%; third: 130-139 mm Hg, n ¼ 654, 19%). Mean WBC count increased linearly across SBP categories (first: 6.1471.54, second: 6.2071.52, third: 6.4171.62, P ¼ 0.02 for trend). There was a linear increase in prevalence of elevated WBC across higher SBP categories (22, 24 and 28%, P ¼ 0.02). As compared to those with SBPo120 mm Hg, in multivariate linear regression analyses (adjusting for age, gender, smoking status, diabetes, body mass index, physical activity, cholesterol/ high-density lipoprotein cholesterol ratio) WBC count was significantly higher among participants with SBP 130-139 mm Hg (regression coefficient: 2.64, 95% confidence interval: 1.04-4.24, P ¼ 0.001). Odds ratio for prevalence of elevated WBC with SBPo120 mm Hg as reference group was 1.14 (0.92-1.41) for SBP 120-129 mm Hg and 1.50 (1.15-1.92) for SBP 130-139 mm Hg. In conclusion, Higher SBP within the normotensive range is also associated with elevated WBC count. Further studies are needed to clarify the role of inflammation in high normal SBP and associated CVD risk.
Introduction
Hypertension affects approximately 50 million individuals in the United States and approximately 1 billion individuals worldwide. 1 Hypertension is a major risk factor for atherosclerosis, cardiovascular disease (CVD) and stroke. 2 The relationship between blood pressure and risk of CVD is continuous, consistent, and independent of other risk factors. For individuals aged 40-70 years, each increment of 20 mm Hg in systolic blood pressure (SBP) or 10 mm Hg in diastolic blood pressure (DBP) doubles the risk of CVD across the entire blood pressure range from 115/75 to 185/115 mm Hg. 3 Recent studies have shown that even high normal blood pressure is associated with an increased risk of CVD. 4 Vasan et al. showed that high normal blood pressure (SBP 130-139 mm Hg, DBP 85-89 mm Hg) as compared to optimal blood pressure (SBPo120 mm Hg and DBPo80 mm Hg) is associated with a risk factoradjusted hazard ratio for CVD of 2.5 (95% confidence interval (CI) 1.6-4.1) in women and 1.6 (95% CI 1.1-2.2) in men.
Several prospective studies have shown a positive and independent association between elevated white blood cell (WBC) count and risk of coronary heart disease (CHD), ischaemic stroke and mortality, [5] [6] [7] [8] suggesting that inflammation plays a key role in the development of CVD. An elevated WBC count is a marker of infection and/or inflammation. White blood cell may also play a role in vascular injury and atherogenesis. [9] [10] [11] WBC-derived macrophages and other phagocytes contribute to endothelial dysfunction, 12 ,13 development of atherosclerotic plaque rupture and thrombosis. 10, 14, 15 Inflammation may also contribute to increasing microvascular capillary resistance, initiation of platelet aggregation, and increased catecholamine levels. 12, [16] [17] [18] Chronic or low-grade inflammation has been shown to be a potential risk factor for hypertension. 16, 18, 19 Recent studies have shown that inflammatory markers such as C-reactive protein (CRP) levels are associated with hypertension. [20] [21] [22] [23] However, little evidence exists whether there is a relationship between inflammation and blood pressure in the high normal range. In this study, we sought to assess the association between WBC, a marker of inflammation, and blood pressure in non-hypertensive healthy asymptomatic middle-aged men.
Research methods and design
Study population This is a cross-sectional study on a consecutive sample of 3484 white asymptomatic individuals free of known coronary artery disease and without a known history of hypertension and/or utilization of oral antihypertensive therapy as well as SBPo 140 mm Hg, who presented for a cardiac risk assessment consisting of a clinical consultation at the Preventive Medicine Center of the Albert Einstein Hospital (Sao Paulo, Brazil) between July 1999 and January 2005. This study was approved by the local institutional review board and received a waiver of patient consent.
Risk factor assessment
All individuals provided details of their demographics, medical history, and medication use at the clinical consultation. Cigarette smoking was considered present if a subject was currently smoking at the time of consultation. Weight, height, waist circumference and blood pressure were determined for each subject. Weight (kg) and height (m) were measured with a standard physician's scale and a stadiometer. Blood pressure (mm Hg) was obtained with a mercury sphygmomanometer (in a sitting position after approximately 5 min) using auscultatory methods following the American Heart Association protocol. 24 Body mass index (BMI) (kg/m 2 ) was calculated using the following formula: weight/height 2 . Blood specimens were collected after an overnight fast. Total cholesterol and triglyceride level were estimated by standard enzymatic methods (cholesterol oxidase/peroxidase-aminophenazone for cholesterol, glycerol phosphate oxidase/peroxidaseaminophenazone for triglycerides) on an automated system using standard kits (Johnson and Johnson Clinical Diagnostics, Rochester, NY, USA). Highdensity lipoprotein cholesterol (HDL-C) was estimated using a precipitation method and low-density lipoprotein cholesterol was calculated (total cholesterol -HDL-C -triglycerides/5) for triglyceride levels up to 400 mg/dl. Fasting blood glucose was measured with a glucose oxidase method using a colourimetric assay on the Vitros automated platform (Johnson and Johnson Clinical Diagnostics, Rochester, NY, USA). Leucocyte count (10 9 /l) was measured automatically in a Sysmex XE 2100 equipment (Roche Diagnostics, Kobe, Japan) (normal range 6-10 Â 10 9 /l). The subjects were divided into three groups according to SBP to assess the association of increasing levels of SBP within the normal range with WBC count. The groups were as follows: first group: SBP o120 mm Hg, n ¼ 1176, 34%; second group: SBP 120-129 mm Hg, n ¼ 1654, 47%; third group: SBP 130-139 mm Hg, n ¼ 654, 19%.
Statistical analysis
Baseline demographics, risk factors and clinical variables were descriptively summarized. Continuous variables were expressed as mean7s.d. Categorical data were presented as per cent frequency. The relationship between WBC count and SBP categories was assessed using univariate and multivariate linear regression analysis. We also employed logistic regression analysis to determine the association between high and normal WBC count (above or below the 75th percentile) and SBP categories, with and without adjustment for confounding variables. The confounding variables that were utilized for the analysis included the following: age, gender, smoking status, BMI, physical activity level, cholesterol/ HDL-C ratio and cholesterol-lowering medication. STATA Statistical Software, Release 8.0 (Stata Corporation Inc., College Station, TX, USA) was used for the analyses. A P-value o0.05 was considered statistically significant.
Results
The study population consisted of 3484 asymptomatic individuals (mean age: 4378 years, 79% males). The mean SBP was 11979 mm Hg. Table 1 shows the baseline characteristics of the study population according to increasing SBP levels within the normotensive range. Those with higher SBP were more likely to be older, male, diabetic and they had a higher BMI and cholesterol/HDL-C ratio. Interestingly, the prevalence of current smoking declined with increasing SBP levels.
The unadjusted WBC levels according to SBP levels are shown in Figure 1 . The lowest WBC counts ( Â 10 9 cells/l) were observed among those with SBPo120 mm Hg (6.171.5) and highest among those with SBP of 130-139 mm Hg (6.471.6) (P ¼ 0.02 for trend). Among men the WBC levels across the increasing SBP showed the same trend across higher SBP levels (SBPo120 mm Hg: 6.171.5, SBP 120-129 mm Hg: 6.271.5 and SBP 130-139 mm Hg: 6.471.6, P ¼ 0.01 for trend), respectively. The mean change in WBC count as expressed by regression coefficients in linear regression analyses adjusting for age was statistically significant among participants with SBP 130-139 mm Hg as compared to those with SBPo 120 mm Hg (P ¼ 0.01). This relationship was robust and persisted even after further adjustment for age, gender, smoking status, diabetes, BMI, physical activity and cholesterol/HDL-C ratio. The WBC counts were significantly higher among participants with SBP 130-139 mm Hg (regression coefficient: 2.64, 95% CI: 1.04-4.24, P ¼ 0.001) as compared to those with SBPo120 mm Hg, whereas a trend was observed among those with SBP of 120-129 mm Hg (P ¼ 0.13) ( Table 2) .
The individuals were also divided into two groups based on their leucocyte counts: high (X75th percentile) and normal (o75th percentile). The prevalence of a high WBC count was highest among those with SBP 130-139 mm Hg and lowest among those with SBPo120 mm Hg (Figure 2) . On logistic regression analysis, the odds of high leucocyte count were significantly higher in group 3 (SBP 130-139 mm Hg) as compared to reference category (group 1; SBPo120), while there was no significant difference between groups 1 and 2. These associations maintained their significance even after adjustment for the above confounding variables (Figure 3 ). Further adjustment with haematocrit or haemoglobin did not alter the results (data not shown).
We also examined the odds ratio of high WBC count (4th quartile) for the SBP levels (130-139 mm Hg) with the lowest SBP count (o120 mm Hg) in subgroups defined by gender and smoking Figure 3 Odds ratio for high white blood cell (WBC) count (475th percentile) with increasing levels of systolic blood pressure (SBP) in normal range. *Adjustment for age, male gender, smoking status, body mass index (BMI), physical activity level, cholesterol/HDL ratio and cholesterol-lowering medication. status ( Figure 4 ). For all subgroups, the odds ratio were consistent with the 50% excess risk seen in the whole cohort, and tests for interaction did not reveal any evidence for effect modification.
Discussion
Several cross-sectional studies have shown a positive relationship between SBP and inflammatory markers including CRP and WBC count. Our study extends and adds to these findings by demonstrating for the first time that increased SBP even within the normotensive range is associated with increased WBC count. Individuals with a high normal SBP were more likely to be in the highest quartile of WBC count. This association persisted after adjustment for age, gender, smoking status, BMI, physical activity level, cholesterol/HDL-C ratio and cholesterol-lowering medications. The mechanism by which high blood pressure is associated with CVD is an active area of research. Several studies have shown that inflammatory markers such as CRP, interleukin (IL)-6 and tumour necrosis factor (TNF)-a are associated with hypertension. Bautista et al. 21 showed an association between CRP, 26 IL-6 and TNF-a and hypertension. Similarly, Sesso et al. 20 showed that elevated CRP levels are associated with future development of hypertension.
Other studies have also shown an association between WBC count and hypertension. In the first National Health and Nutrition Examination Survey (NHANES I) Epidemiologic Follow-up Study (NHFS), Gillum and Mussolino 19 showed that increased WBC count was associated with an increased incidence of hypertension in white men, and possibly older white and black women. However, no positive association between increased WBC count and the incidence of hypertension was seen in black men. In a matched case-control study, Friedman et al. 16 reported a 40% increase in the risk of hypertension in the whole cohort comparing the highest to the lowest quartile of WBC count.
However, little is known about the association of inflammation and blood pressure within the normotensive range. To our knowledge, ours is the first study to report an association between WBC count and high blood pressure in normotensive patients. Vasan et al. 4 showed that even high normal blood pressure was associated with increased risk of CVD. They investigated the association between bloodpressure category at baseline and the incidence of CVD in a prospective study among 6859 participants in the Framingham Heart Study who were initially free of hypertension and CVD. A stepwise increase in cardiovascular event rates was noted in persons with higher baseline blood-pressure categories. As compared with optimal blood pressure (SBPo120 mm Hg and DBPo80 mm Hg), highnormal blood pressure (SBP 130-139 mm Hg and DBP 85-89 mm Hg) was associated with a risk factor adjusted hazard ratio for CVD of 2.5 (95% CI 1.6-4.1) in women and 1.6 (95% CI 1.1-2.2) in men.
As a result of the elevated risk of CVD associated with even high-normal blood pressure, the seventh report of the Joint National Committee (JNC) on prevention, detection, evaluation and treatment of high blood pressure classified adults with SBP 120-139 mm Hg or DBP 80-89 mm Hg as pre-hypertensive as opposed to high normal in the JNC VI report. 1 Our findings in part may explain the increased risk of CVD with high normal blood pressure.
As smoking is associated with an increase in WBC count 26, 27 and also with the development of hypertension, it may act as a confounding factor. Therefore, we adjusted for smoking in our main analyses and also performed analyses stratified by smoking status. The association between WBC count and SBP persisted after adjustment for smoking. Shankar et al. 28 showed that increasing tertiles of WBC count were associated with an increased risk ratio of hypertension among current, former and never smokers for the whole cohort. The risk was statistically significant only among current and former male smokers. In contrast, Nakanishi et al. 29 found that SBP and DBP levels increased as WBC count increased in both never smokers and ex-smokers.
Elevated WBC count has been shown to be associated with the risk of various CVDs. 30, 31 Leucocytes may play a key role in the development of atherosclerosis. 32 However, the role of leucocytes in hypertension still remains unclear. Peripheral polymorphonuclear leucocytes are activated in essential hypertension. 33 A number of biological mechanisms have been suggested to explain the role of WBC in hypertension. 34 Since inflammation causes endothelial dysfuntion, stimulated granulocytes and monocytes may release a variety of vasoactive substances resulting in the formation of oxygen-derived free radicals; 35 this may influence vascular tone either indirectly by inactivating endothelium-derived relaxing factor 36 and reducing the release of prostacyclin, 37 or directly by promoting smooth muscle cell contraction. 38 This may result in the loss of vasodilator, antithrombotic and antiatherogenic properties of the vascular endothelium. 13, 39 In addition, stimulated granulocytes also release cathepsin G, which generates the potent vasoconstrictor angiotensin II by activation of prorenin to renin 40 and also by cleaving angiotensin II directly from angiotensinogen or angiotensin I. 41 Stimulated granulocytes may have altered rheological properties with an increased tendency to adhere to vascular endothelium resulting in capillary leucostasis and subsequent increased vascular resistance. 42, 43 Moreover, stimulated leucocytes release eicosanoids, platelet-activating factor and oxygenderived free radicals, which may initiate platelet aggregation 44 and release of potent vasoconstrictors serotonin and thromboxane A2; 45 this may produce microvascular obstruction by thrombus formation. An elevated WBC count may also be a marker for a state characterized by increased catecholamine levels or sympathetic nervous system activity, 16 which can raise blood pressure and may eventually result in sustained hypertension. 46 Recently, Abramson et al. 23 showed that increased blood pressure was also associated with increased inflammation. Elevated levels of blood pressure are associated with impaired acetylcholine-induced endothelium-dependent relaxation, which is prevented by administration of antioxidant superoxide dismutase. 47 This has led to the hypothesis that high blood pressure may impair endothelium-dependent relaxation by generating reactive oxygen species, 47 which in turn can stimulate an inflammatory signaling pathway. 48 White blood cell count is a simple and inexpensive test, which is associated with high blood pressure. Other inflammatory markers such as CRP, 20, 25 IL-6 and TNF-a 21 are associated with high blood pressure as well. Despite the potential importance of these novel biochemical markers, many of them are not routinely available. On the other hand, the WBC count is universally available and is one of the most commonly obtained tests. Further research is needed, however, to assess the comparative roles of WBC count with other inflammatory markers such as CRP.
The limitations of our study include its crosssectional nature; thus, a temporal relationship between WBC count and high blood pressure cannot be established. The cross-sectional nature of this study also does not allow us to exclude the hypothesis that an increase in inflammation may lead to higher blood pressure. White blood cell differentials were also not available for analysis. Thus, it cannot be ascertained which subtype of WBC are associated with high blood pressure. Our subjects were Brazilian and thus the association of WBC count and high blood pressure in different racial groups could not be studied. We cannot exclude the possibility that the higher WBC count may be due to an unaccounted source of infection. However, our study population consisted of healthy middle-aged men and women. Also in our study we did not have information on alcohol use as Nakanishi et al. 49 has suggested that alcohol use may suppress WBC count. However, all patients in our study were instructed not to consume alcohol 48 h before blood collection.
In conclusion, our study shows that increasing SBP even within the normotensive range is associated with an increased WBC count. The WHO-ISH report 50 emphasized the 'rationale for expecting high-risk subjects without hypertension to benefit from blood pressure lowering and the need for clinical trials to investigate this possibility'. Further studies are needed to better define the role of inflammation in high normal/pre-hypertensive blood pressure range and the associated CVD risk. This will also help to clarify whether lowering highnormal blood pressure can decrease the associated inflammation and reduce the risk of CVD. In addition, recognition of the WBC-hypertension relationship may also help to elucidate the pathogenesis of essential hypertension.
What is known about this topic K Hypertension is a major risk factor for atherosclerosis, cardiovascular disease (CVD), and stroke. 2 
K
Recent studies have shown that even high-normal blood pressure is associated with an increased risk of cardiovascular disease. 4 
There is a positive and independent association between elevated white blood cell (WBC) count and risk of coronary heart disease (CHD), ischaemic stroke, and mortality, [5] [6] [7] [8] suggesting that inflammation plays a key role in the development of CVD.
Chronic or low-grade inflammation has also been shown to be a potential risk factor for hypertension. 16, 18, 19 K WBC may play a role in vascular injury and atherogenesis. [9] [10] [11] K Recent studies have shown that inflammatory markers such as C-reactive protein levels are associated with hypertension. [20] [21] [22] [23] K However, little evidence exists whether there is a relationship between inflammation and blood pressure within the normotensive range.
What this study adds K To our knowledge this is the first study assessing the association between WBC, a marker of inflammation, and blood pressure within the normotensive range.
We found that increased systolic blood pressure even within the normotensive range is associated with increased WBC count, and thus inflammation.
This raises an important question; whether lowering highnormal blood pressure can decrease the associated inflammation and reduce the associated CVD risk.
